Tag: CLARITY Phase 3 trial
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the U.S.
LENZ Therapeutics, Inc. announced VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults,...
